首页> 外文期刊>Drug development and industrial pharmacy >Construction and cellular uptake evaluation of redox-responsive docetaxel prodrug self-assembled nanoparticles
【24h】

Construction and cellular uptake evaluation of redox-responsive docetaxel prodrug self-assembled nanoparticles

机译:氧化还原响应多西紫杉醇前药自组装纳米粒子的构建与蜂窝摄取评价

获取原文
获取原文并翻译 | 示例
           

摘要

Docetaxel (DTX) solution has some serious adverse side effects. A redox-responsive DTX prodrug synthesized in our laboratory was used to prepare DTX prodrug self-assembled nanoparticles (DSNPs) with the method of nanoprecipitation. This study aimed at optimizing the formulation to develop stable preparation for the delivery of DTX. Single-factor test was used to evaluate the effects of the preparation concentration of DTX prodrug, stirring speed, the types of stabilizers and temperature on the prescription process of DSNPs. The particle size and polydispersity index were selected as the evaluation indexes. The entrapment efficiency, drug-loading, size distribution and zeta potential were characterized by UPLC and Zetasizer, respectively. The stability and cellular behavior of DSNPs were investigated by Zetasizer, LC–MS/MS and confocal laser scanning microscope, respectively. The particle size, entrapment efficiency and drug-loading of DSNPs were 173.8 ± 1.4 nm, 98.8% ± 0.1%, and 47.8% ± 0.9%, respectively. DSNPs showed good stability during the storage of 30 days, and were taken into the cells in a time-dependent and concentration-dependent manner. The method of nanoprecipitation could be used to entrap DTX. The preparation method was simple, and the quality of DSNPs was stable and reliable. Through the optimization of the formulation, we obtained uniform and stable DSNPs, which could escape from lysosomes of tumor cells. The optimized formulations were stable for intravenous administration. This study could provide scientific support for the development of nano-drug delivery system of small anti-tumor drug.
机译:多西紫杉醇(DTX)解决方案具有一些严重的不良副作用。在我们实验室中合成的氧化还原响应性DTX前药用纳米沉淀方法制备DTX前药自组装纳米颗粒(DSNP)。本研究旨在优化制剂,以开发稳定的DTX递送制剂。单因素试验用于评估DTX前药,搅拌速度,稳定剂类型和温度的制备浓度对DSNP的处方过程的影响。选择粒度和多分散性指数作为评估指标。通过UPLC和Zetasizer分别表征夹带效率,药物负荷,尺寸分布和Zeta电位。通过Zetasizer,LC-MS / MS和共聚焦激光扫描显微镜研究了DSNP的稳定性和细胞行为。 DSNP的粒度,夹带效率和药物负载分别为173.8±1.4nm,98.8%±0.1%,分别为47.8%±0.9%。 DSNP在30天内储存期间显示出良好的稳定性,并且以时间依赖性和浓度依赖性方式进入细胞。纳米尺寸的方法可用于诱捕DTX。制备方法简单,DSNP的质量稳定可靠。通过优化配方,我们获得了均匀且稳定的DSNP,其可以从肿瘤细胞的溶酶体中逸出。优化的制剂对于静脉内给药稳定。本研究可以为小抗肿瘤药物的纳米药物输送系统进行科学支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号